Antibiotic prophylaxis and surgical site infections in orthognathic surgery - a retrospective analysis.


Journal

BMC oral health
ISSN: 1472-6831
Titre abrégé: BMC Oral Health
Pays: England
ID NLM: 101088684

Informations de publication

Date de publication:
25 09 2023
Historique:
received: 08 10 2022
accepted: 05 09 2023
medline: 26 9 2023
pubmed: 25 9 2023
entrez: 24 9 2023
Statut: epublish

Résumé

This study was conducted to determine surgical site infection (SSI) rates and potential risk factors as well as to evaluate antibiotic prophylaxis in orthognathic surgery. This retrospective observational study included patients who received orthognathic surgery. SSIs and their management were assessed for up to one year post-operatively. The applied antibiotic regime and other possible influencing factors (smoking, age, site of infection, drainage, duration of surgery, displacement distances, craniofacial malformations) were assessed. In total 291 patient met the inclusion criteria (56.7% female). The mean age at surgery was 25.5 ± 8.5 years. Fifty-four patients (18.6%) were diagnosed with a craniofacial malformation. Relevant previous surgeries were documented in about one quarter of included patients (n = 75). Ninety-two percent of patients (n = 267) received intraoperative single-dose antibiotic prophylaxis. Surgical site infections occurred in 12.4% (n = 36) of patients. There was a significant association between postoperative infections and type of surgery (P = .037) as well as type of drainage (P = .002). Statistical analyses also revealed a higher prevalence of smokers (P = .036) and previous surgically assisted rapid palatal expansion (SARPE) (P = .018) in the infection group. Furthermore, no significant relationships were observed between postoperative infections and various co-factors (i.e. antibiotic regime, age at surgery, gender, associated craniofacial malformations, surgery duration, displacement distances, mandibular setback vs. advancement). Low rates of SSIs occurred following an intraoperative single-dose antibiotic regime. None of the SSIs had a significant effect on the final surgical outcome. Present data do not warrant escalation of the antibiotic regimen. Postoperative smoking and capillary drainage should be avoided.

Sections du résumé

BACKGROUND
This study was conducted to determine surgical site infection (SSI) rates and potential risk factors as well as to evaluate antibiotic prophylaxis in orthognathic surgery.
METHODS
This retrospective observational study included patients who received orthognathic surgery. SSIs and their management were assessed for up to one year post-operatively. The applied antibiotic regime and other possible influencing factors (smoking, age, site of infection, drainage, duration of surgery, displacement distances, craniofacial malformations) were assessed.
RESULTS
In total 291 patient met the inclusion criteria (56.7% female). The mean age at surgery was 25.5 ± 8.5 years. Fifty-four patients (18.6%) were diagnosed with a craniofacial malformation. Relevant previous surgeries were documented in about one quarter of included patients (n = 75). Ninety-two percent of patients (n = 267) received intraoperative single-dose antibiotic prophylaxis. Surgical site infections occurred in 12.4% (n = 36) of patients. There was a significant association between postoperative infections and type of surgery (P = .037) as well as type of drainage (P = .002). Statistical analyses also revealed a higher prevalence of smokers (P = .036) and previous surgically assisted rapid palatal expansion (SARPE) (P = .018) in the infection group. Furthermore, no significant relationships were observed between postoperative infections and various co-factors (i.e. antibiotic regime, age at surgery, gender, associated craniofacial malformations, surgery duration, displacement distances, mandibular setback vs. advancement).
CONCLUSION
Low rates of SSIs occurred following an intraoperative single-dose antibiotic regime. None of the SSIs had a significant effect on the final surgical outcome. Present data do not warrant escalation of the antibiotic regimen. Postoperative smoking and capillary drainage should be avoided.

Identifiants

pubmed: 37743500
doi: 10.1186/s12903-023-03391-3
pii: 10.1186/s12903-023-03391-3
pmc: PMC10518949
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Observational Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

688

Informations de copyright

© 2023. BioMed Central Ltd., part of Springer Nature.

Références

Am J Infect Control. 1992 Oct;20(5):271-4
pubmed: 1332552
Int J Oral Maxillofac Surg. 2023 Feb;52(2):219-226
pubmed: 35760661
Semin Plast Surg. 2013 Aug;27(3):149-54
pubmed: 24872761
Int J Oral Maxillofac Surg. 2023 Feb;52(2):211-218
pubmed: 35780069
J Oral Maxillofac Surg. 1990 Jun;48(6):617-20
pubmed: 2341942
Medicina (Kaunas). 2022 Feb 10;58(2):
pubmed: 35208586
J Oral Maxillofac Surg. 2011 Oct;69(10):2650-6
pubmed: 21549486
J Oral Maxillofac Surg. 2012 Jul;70(7):1643-7
pubmed: 21958665
Yonsei Med J. 2009 Feb 28;50(1):55-9
pubmed: 19259349
J Craniomaxillofac Surg. 2019 Feb;47(2):228-232
pubmed: 30578013
J Oral Maxillofac Surg. 2007 May;65(5):984-92
pubmed: 17448852
J Oral Surg. 1975 Jun;33(6):412-26
pubmed: 1055202
Sci Rep. 2020 Jul 21;10(1):12015
pubmed: 32694715
Int J Oral Maxillofac Surg. 2013 Mar;42(3):352-5
pubmed: 23265757
Rev Stomatol Chir Maxillofac. 2009 Jun;110(3):127-34
pubmed: 19410270
J Oral Maxillofac Surg. 2010 Feb;68(2):344-6
pubmed: 20116706
J Oral Maxillofac Surg. 2016 Jun;74(6):1199-206
pubmed: 26917207
J Craniomaxillofac Surg. 2005 Feb;33(1):24-9
pubmed: 15694146
J Stomatol Oral Maxillofac Surg. 2022 Nov;123(6):e936-e939
pubmed: 35697252
Br J Oral Maxillofac Surg. 2021 Jul;59(6):633-642
pubmed: 34016464
Br J Oral Maxillofac Surg. 2004 Dec;42(6):506-10
pubmed: 15544879
Oral Surg Oral Med Oral Pathol. 1957 Jul;10(7):677-89; contd
pubmed: 13441284
J Oral Surg. 1968 Apr;26(4):250-3
pubmed: 5237786
J Oral Maxillofac Surg. 2017 Apr;75(4):796-804
pubmed: 27789268
J Oral Surg Anesth Hosp Dent Serv. 1961 Jan;19:42-7
pubmed: 13719390
Eur J Surg Oncol. 2016 Nov;42(11):1756-1758
pubmed: 27554249
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2003 Feb;95(2):145-9
pubmed: 12582352
J Oral Maxillofac Surg. 2017 Mar;75(3):584-595
pubmed: 27746257
Trials. 2021 Nov 2;22(1):762
pubmed: 34727951
PLoS One. 2018 Jan 31;13(1):e0191161
pubmed: 29385159

Auteurs

Andreas Naros (A)

Department of Oral and Maxillofacial Surgery, Tuebingen University Hospital, Osianderstrasse 2-8, Tuebingen, 72076, Germany.

Carola Helene Naros (CH)

Department of Oral and Maxillofacial Surgery, Tuebingen University Hospital, Osianderstrasse 2-8, Tuebingen, 72076, Germany.

Daniel Awad (D)

Department of Oral and Maxillofacial Surgery, Tuebingen University Hospital, Osianderstrasse 2-8, Tuebingen, 72076, Germany.

Michael Krimmel (M)

Department of Oral and Maxillofacial Surgery, Tuebingen University Hospital, Osianderstrasse 2-8, Tuebingen, 72076, Germany.

Susanne Kluba (S)

Department of Oral and Maxillofacial Surgery, Tuebingen University Hospital, Osianderstrasse 2-8, Tuebingen, 72076, Germany. susanne.kluba@med.uni-tuebingen.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH